The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Netea, M. G.
Right arrow Articles by Kullberg, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Netea, M. G.
Right arrow Articles by Kullberg, B. J.
The Journal of Immunology, 1999, 163: 1498-1505.
Copyright © 1999 by The American Association of Immunologists

Increased Susceptibility of TNF-{alpha} Lymphotoxin-{alpha} Double Knockout Mice to Systemic Candidiasis Through Impaired Recruitment of Neutrophils and Phagocytosis of Candida albicans

Mihai G. Netea*, Lambertus J. H. van Tits*, Jo H. A. J. Curfs{dagger}, Franck Amiot{ddagger}, Jacques F. G. M. Meis{dagger}, Jos W. M. van der Meer* and Bart Jan Kullberg1,*

Departments of * Medicine and {dagger} Medical Microbiology, University Hospital Nijmegen, Nijmegen, The Netherlands; and {ddagger} Laboratoire d’Étude des Mécanismes de la Régulation de la Recombinaison Génétique, Unite Mixte de Recherche, Commissariat a l’Energie Atomique/Centre National de la Recherche Scientifique, Fontenay aux Roses, France


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
TNF-{alpha} and lymphotoxin-{alpha} (LT) are members of the TNF family, and these cytokines play crucial roles in the defense against infection with Candida albicans. The aim of the present study was to investigate the role of endogenous TNF and LT during disseminated candidiasis in TNF-/-LT-/- knockout mice. The TNF- and LT-deficient animals had a significantly increased mortality following C. albicans infection compared with control mice, and this was due to a 10- to 1000-fold increased outgrowth of the yeast in their organs. No differences between TNF-/-LT-/- mice and TNF+/+LT+/+ were observed when mice were rendered neutropenic, suggesting that activation of neutrophils mediates the beneficial effects of endogenous TNF and LT. Histopathology of the organs, combined with neutrophil recruitment experiments, showed a dramatic delay in the neutrophil recruitment at the sites of Candida infection in the TNF-/-LT-/- mice. Moreover, the neutrophils of deficient animals were less potent to phagocytize Candida blastospores than control neutrophils. In contrast, the killing of Candida and the oxygen radical production did not differ between neutrophils of TNF-/-LT-/- and TNF+/+LT+/+ mice. Peak circulating IL-6 was significantly higher in TNF-/-LT-/- mice during infection. Peritoneal macrophages of TNF-/-LT-/- mice did not produce TNF, and synthesized significantly lower amounts of IL-1{alpha}, IL-1{beta}, IL-6, and macrophage-inflammatory protein-1{alpha} than macrophages of TNF+/+LT+/+ animals did. In conclusion, endogenous TNF and/or LT contribute to host resistance to disseminated candidiasis, and their absence in TNF-/-LT-/- mice renders the animals susceptible through impaired recruitment of neutrophils and impaired phagocytosis of C. albicans.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Acute disseminated candidiasis is a life-threatening disease that occurs predominantly in immunocompromised patients. Despite development of new antifungal drugs, mortality associated with disseminated candidiasis remains high (1), and additional therapies directed toward the augmentation of host defense mechanisms would be a rational approach. Therefore, a better understanding of the mechanisms responsible for the defense against an invasive Candida infection is required to develop strategies aimed to boost the anticandidal actions of the immune system.

TNF-{alpha} and lymphotoxin-{alpha} (LT)2are members of the TNF family of cytokines (2). Although they have different structures, both TNF and LT bind to the same TNF receptors, induce overlapping intracellular pathways, and lead to similar biological effects (3). On the one hand, these cytokines are considered to be potentially deleterious mediators of the inflammatory responses that occur during sepsis (4), and anti-TNF Abs protect against lethal endotoxemia and i.v. Gram-negative infections in experimental models (5, 6). On the other hand, endogenous TNF production is necessary for the normal immune response against an invading microorganism, as has been demonstrated in various experimental models (7, 8, 9). TNF also has important roles in host defense against disseminated candidiasis. It has been shown that mannoprotein constituents from the Candida albicans cell wall are able to induce the production of TNF both in vitro (10) and in vivo (11), and neutralization of endogenous TNF by either anti-TNF Abs or pharmacological agents has deleterious effects on the course of experimental disseminated candidiasis (12, 13). The crucial role of TNF-like molecules during C. albicans infection has been underlined recently by experiments in mice lacking TNF receptors, which were found to be highly susceptible to systemic candidiasis (14). However, the underlying mechanisms responsible for the high susceptibility of these genetically modified animals to Candida infection have not been identified.

There are several lines of evidence that suggest that neutrophils are the main cellular component of the immune system responsible for the defense against C. albicans (15). The growth of C. albicans in vitro is inhibited by polymorphonuclear neutrophils (16), granulocytopenic mice are highly susceptible to disseminated candidiasis (17), and the stimulation of neutrophil function by IFN-{gamma} (18) or granulocyte CSF (19) improves the outcome of experimental infection with C. albicans. TNF is also able to strongly potentiate the function of neutrophils, resulting in activation of microbicidal mechanisms such as superoxide production, with an increased ability of the cells to kill Candida (20, 21). It is therefore reasonable to hypothesize that the increased susceptibility to disseminated candidiasis in genetically manipulated mice lacking signals mediated by cytokines of the TNF family may be mediated through impaired neutrophil function. The aim of the present study was to establish the mechanisms through which endogenous TNF and LT protect against C. albicans infection. We assessed the course of disseminated candidiasis in TNF and LT double knockout (TNF-/-LT-/-) mice, and we investigated the mechanisms responsible for the impaired defense against Candida in these genetically modified animals.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals

Homozygous TNF-/-LT-/- and heterozygous TNF+/-LT+/- mice were produced as previously described (22). Specific pathogen-free knockout mice and age- and weight-matched TNF+/+LT+/+ control mice (20–25 g, 6–8 wk old) were used. Mice were fed sterilized laboratory chow (Hope Farms, Woerden, The Netherlands) and water ad libitum.

C. albicans infection model

C. albicans UC 820, a clinical isolate well described earlier (23), has been used in all experiments. Mice were injected i.v. with C. albicans (104–106 CFU/mouse) in a 100 µl volume of sterile pyrogen-free PBS, as indicated. Survival was assessed daily for 30 days in groups of at least 20 animals per group. At the end of the observation period, the surviving mice were anesthetized with ether and killed by cervical dislocation. In addition, subgroups of five animals were killed on day 1, 3, or 7 of infection, and blood was collected on EDTA for plasma cytokine concentration measurements. To assess the outgrowth of the microorganisms, the liver, spleen, and left kidneys of the sacrificed animals were removed aseptically, weighed, and homogenized in sterile saline in a tissue grinder. The number of viable Candida cells in the tissues was determined by plating serial dilutions on Sabouraud dextrose agar plates, as previously described (24). The CFU were counted after 24 h of incubation at 37°C, and expressed as log CFU/g tissue. From the same animals, the right kidneys were fixed in Formalin (4%) and embedded in paraffin, and serial sections were examined microscopically after staining with a combination of periodic acid Schiff and hematoxylin-eosin. Circulating leukocytes were counted using a hemacytometer, and differentiation was assessed microscopically after Giemsa staining.

To examine the distribution and clearance of C. albicans in the early stages of infection, groups of mice were infected with 106 CFU of C. albicans i.v., and subgroups of five animals were sacrificed 1, 2, 4, 8, and 24 h postinfection. The distribution of C. albicans in the liver, spleen, kidneys, lungs, heart, brain, and blood was assessed as described above.

To investigate the role of polymorphonuclear neutrophils (PMN) in the Candida infection in TNF-/-LT-/- mice, groups of deficient and normal mice were rendered neutropenic by pretreatment with cyclophosphamide (Bristol-Myers Squibb, Weesp, The Netherlands): 150 mg/kg was administered s.c. 4 days before infection, followed by 100 mg/kg 1 day before infection, as well as 1, 3, 5, 7, and 9 days after i.v. injection of 104 CFU C. albicans. This treatment leads to a profound and prolonged neutropenia, as has been described previously (25, 26, 27). Daily differential counts in peripheral blood smears confirmed that granulocytes remained <100 x 106/L throughout the infection (data not shown). The outgrowth of the microorganisms in the organs at days 1 and 3 of infection, and the survival of mice during disseminated candidiasis in neutropenic mice was investigated as described above.

Recruitment of neutrophils

To investigate the recruitment of PMN at the site of Candida infection, groups of five TNF-/-LT-/- mice and wild-type littermates were injected i.p. with 107 CFU C. albicans. After 2 and 4 h, peritoneal cells were collected in sterile saline containing 0.38% sodium citrate, and the total cell number was counted in a hemacytometer. The percentage and the absolute numbers of neutrophils were determined in Giemsa-stained cytocentrifuge preparations.

Phagocytosis and killing of C. albicans by neutrophils

Exudate peritoneal PMN were obtained, and phagocytosis and killing were performed as previously described (18). Briefly, groups of five TNF-/-LT-/- mice and wild-type littermates were injected i.p. with 1 ml of 10% proteose peptone, and after 4 h the exudate cells were collected in separate sterile tubes, as described above (18). Peritoneal cells were washed, counted, and resuspended in RPMI 1640 medium (Flow Laboratories, Irvine, CA). The number of cells was adjusted to 5 x 105 PMN/ml. Four hours after injection of proteose peptone, the peritoneal cell population of control mice consisted of 86–97% PMN and 3–14% macrophages. In contrast, the TNF-/-LT-/- mice have a 5- to 8-fold higher population of resident peritoneal macrophages than controls (28), resulting in a substantial percentage of macrophages (40–60%) in the peritoneal exudate 4 h after proteose peptone. A decreased recruitment of PMN after proteose peptone in TNF-/-LT-/- mice (data not shown), similar to that observed after Candida administration, also contributed to this distorted neutrophil to macrophage ratio. Although macrophages are poor in killing C. albicans, and therefore unlikely to disturb the killing assay (18), to correct for this difference between TNF-/-LT-/- and TNF+/+LT+/+ mice, resident peritoneal macrophages from a separate group of TNF-/-LT-/- mice were collected, and added to the peritoneal exudate of TNF+/+LT+/+ mice, in concentrations adjusted to obtain similar PMN/macrophage proportions as in the knockout mice. Subsequently, 5 x 104 CFU C. albicans were added to the cell suspension (PMN to Candida ratio 10:1), and the mixtures were incubated at 37°C in 10 ml silicone-coated tubes (Sherwood Medical, Ballymoney, N. Ireland) under continuous slow rotation.

To assess phagocytosis, a 100 µl sample was taken from each tube after 5 or 15 min of incubation and centrifuged (500 x g, 10 min). The supernatant containing the uningested microorganisms was discarded, and the cells were washed twice in PBS. Light microscopy confirmed that the Candida blastospores were phagocytized, and that no extracellular or attached microorganisms were present. Lysis of the PMN was performed in water containing 0.01% BSA (Sigma, St. Louis, MO). Serial dilutions of the suspension containing the intracellular yeasts were plated on Sabouraud agar plates, and the C. albicans were counted after 24 h of incubation (18). To confirm the role of TNF in the phagocytosis process, PMN of TNF-/-LT-/- mice were coincubated with 1 ng/ml of exogenous murine rTNF (a kind gift of Dr. G. R. Adolf, Bender GmbH, Vienna, Austria), during the phagocytosis assay.

Killing of C. albicans by PMN was assessed in the same cell suspension. After the initial 15-min incubation time to allow for the phagocytosis of blastospores, the tubes were gently centrifuged as described above, and the uningested extracellular Candida cells were discarded. The cells were resuspended in RPMI 1640, and before incubation and after 1-, 2-, and 3-h incubation at 37°C under rotation, a 100 µl sample from each tube was taken, cells were lysed, and C. albicans CFU were enumerated after 24 h of culture on Sabouraud agar plates. Microscopic examination and repeated washes revealed that no C. albicans blastospores were clumped or remained attached to the tubes. The number of viable intracellular C. albicans colonies after each of the incubation periods represented the amounts of yeasts not killed by the cells. The percentage killing of Candida was defined as [1 - (CFU after incubation/CFU recovered at the start of incubation)] x 100.

Superoxide production

PMN from TNF-/-LT-/- and normal mice were collected 4 h after i.p. injection of proteose peptone, as described above. Luminol-enhanced chemoluminescence of proteose-peptone-elicited PMN was measured on a Victor 1420 counter (Wallac, Turku, Finland) at 20°C using white 96-well microplates (Costar, Cambridge, MA), as previously described (29). Each well contained 2 x 105 cells, 50 µM luminol, 4.5 U/ml horseradish peroxidase, and 50 ng/ml PMA in 200 µl of HBSS without phenol red (Life Technologies, Paisley, Scotland) supplemented with 0.25% human albumin (Behringwerke, Marburg, Germany). Reactions were started by adding PMA. Each experiment was performed in duplicate. HRP was added to the system to overcome peroxidase deficiency extracellularly. In previous experiments, we found that the addition of extra peroxidase did not affect superoxide production (measured as reduction of cytochrome c) of human neutrophils stimulated with PMA, but increased luminol-enhanced chemoluminescence 3- to 4-fold. Hence, solely the detection of superoxide is enhanced in the presence of extra peroxidase. The chemoluminescence was expressed as the total amount of superoxide produced during the assay period by integrating the area under the curve (in mV.s) per PMN.

Ex vivo cytokine production

Uninfected TNF-/-LT-/- mice and wild-type controls were sacrificed, and resident peritoneal macrophages were harvested by injecting 4 ml of sterile PBS containing 0.38% sodium citrate (18). After centrifugation and washing, the cells were resuspended in RPMI 1640 containing 1 mM pyruvate, 2 mM L-glutamine, 100 µg/ml gentamicin, and 2% fresh mouse plasma (culture medium). Cells were cultured in 96-well microtiter plates (Costar) at 105 cells/well, in a final volume of 200 µl. The cells were stimulated with either 1 ng/ml LPS (Escherichia coli serotype O55:B5; Sigma) or heat-killed (1 h, 100°C) C. albicans 107 CFU/ml. After 24 h of incubation at 37°C, the plates were centrifuged (500 x g, 10 min), and the supernatant was collected and stored at -80°C until cytokine assays were performed. To assess the cell-associated cytokines, 200 µl of culture medium was added to the remaining cells, and the membranes were disrupted by three freeze-thaw cycles. The samples were stored at -80°C until measurements.

Cytokine assays

IL-1{alpha}, IL-1{beta}, and TNF-{alpha} were determined by specific RIAs (detection limit 20 pg/ml), as previously described (30). IL-6 concentrations were measured by a commercial ELISA (CLB, Amsterdam, The Netherlands; detection limit 16 pg/ml), according to the instructions of the manufacturer. Macrophage-inflammatory protein-1{alpha} (MIP-1{alpha}) concentrations were measured by a commercial ELISA (R&D Systems, Abingdon, U.K.; detection limit 24 pg/ml), according to the instructions of the manufacturer.

Statistical analysis

The differences between groups were analyzed by Mann-Whitney U test, and where appropriate by Kruskal-Wallis ANOVA test. Survival curves were analyzed by the Kaplan-Meyer log rank test. The level of significance between groups was set at p < 0.05. All experiments were performed at least twice, and the data are presented as cumulative results of all experiments performed.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
C. albicans infection model

After infection of mice with 106 CFU C. albicans, all of the TNF-/-LT-/- and TNF+/-LT+/- mice died, whereas only 40% of the wild-type mice died (p < 0.01). Similarly, after an infection with 5 x 104 CFU C. albicans, the mortality of both homozygous and heterozygous knockout mice was significantly higher when compared with the normal mice (p < 0.01) (Fig. 1Go). This was probably due to the load of C. albicans in the organs, because the numbers of CFU on days 1, 3, and 7 postinfection were significantly higher in the organs of TNF-/-LT-/- mice, and on day 7 also in the organs of TNF+/-LT+/- mice, than in those of TNF+/+LT+/+ mice (Fig. 2Go and Table IGo). The distribution of C. albicans to the liver, spleen, heart, lung, brain, and blood during the initial 24 h of infection did not differ between the TNF-/-LT-/- and TNF+/+LT+/+ mice (data not shown). The insert to Fig. 2Go shows the numbers of C. albicans in the kidneys of TNF-/-LT-/- and TNF+/+LT+/+ mice during the first 24 h after infection, and demonstrates that the early distribution of C. albicans to the organs is similar, and that the differences observed at late time points are due to different rates of outgrowth in the organs of the two mouse strains.



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 1. Survival of mice after C. albicans infection. Wild-type TNF+/+LT+/+ mice ({circ}), heterozygous TNF+/-LT+/- mice ({blacktriangleup}), and homozygous TNF-/-LT-/- mice ({triangleup}) were infected i.v. with 5 x 104 CFU Candida per mouse. Both homozygous and heterozygous deficient mice had an increased mortality compared with wild-type controls (p < 0.01, log rank test).

 


View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 2. Growth of C. albicans in the kidneys. Outgrowth of C. albicans in the kidneys of wild-type TNF+/+LT+/+ mice ({circ}), heterozygous TNF+/-LT+/- mice ({blacktriangleup}), and homozygous TNF-/-LT-/- mice ({triangleup}) after i.v. infection of 5 x 104 CFU Candida per mouse (mean ± SD of 10 mice/group). Significant differences between wild-type and knockout mice are indicated (*, p < 0.05). Insert, No differences in the early distribution (the first 24 h) of C. albicans between TNF+/+LT+/+ and TNF-/-LT-/- mice, injected with 106 CFU C. albicans per mouse.

 

View this table:
[in this window]
[in a new window]
 
Table I. The outgrowth of C. albicans in the organs of non neutropenic mice after i.v. injection of 5 x 104 CFU C. albicans/mouse

 
Histopathology of the kidneys of TNF+/+LT+/+ mice showed large PMN infiltrates on days 1 and 3 after infection with 5 x 104 CFU Candida, with controlled growth of small numbers of yeasts, without hyphal formation (Fig. 3Go). On day 7 after infection, the kidneys of the TNF+/+LT+/+ mice appeared almost completely healed. In contrast, very few infiltrating neutrophils were present in the kidneys of TNF-/-LT-/- mice on days 1 and 3 after infection, with extensive growth of Candida, which had formed numerous hyphae and pseudohyphae. On day 7, despite the presence of large infiltrates of PMN, Candida was present in large numbers in the centers of the infiltrates in the kidneys of TNF-/-LT-/- mice (Fig. 3Go). In contrast to the low numbers of PMN in the infected tissues of TNF-/-LT-/- mice, circulating concentrations of PMN tended to be higher in the TNF-/-LT-/- than in TNF+/+LT+/+ mice on both day 1 (3.9 ± 1.5 vs 2.4 ± 0.9 x 109/L, p = 0.09) and day 3 (4.6 ± 1.9 vs 2.6 ± 1.1 x 109/L, p = 0.06) after infection, suggesting that the PMN of the knockout mice remain in the circulation rather than migrating to the infected tissues.



View larger version (163K):
[in this window]
[in a new window]
 
FIGURE 3. Histopathology of the kidneys in the Candida-infected mice. In TNF+/+LT+/+ mice, there are large PMN infiltrates on days 1 (A) and 3 (C), with controlled growth of C. albicans blastospores (arrows). On day 7 (E), the kidneys of TNF+/+LT+/+ mice appear to be healed. In TNF-/-LT-/- mice, small size neutrophil infiltrates in the kidneys on days 1 (B) and 3 (D) of infection, with extensive growth of Candida blastospores and hyphae. On day 7 (F), large infiltrates of PMN, but failure to control the growth of Candida. Periodic acid Schiff (PAS) combined with hematoxylin-eosin (HE) staining. Original magnification x400.

 
TNF concentrations were undetectable in the circulation of TNF-/-LT-/- and TNF+/-LT+/- mice, and were 80 ± 34 pg/ml (day 1) and 224 ± 168 pg/ml (day 3) in the TNF+/+LT+/+ mice. On day 7, TNF blood concentrations in controls had returned to undetectable levels. IL-1{alpha} and IL-1{beta} were below the detection limit at all time points. Peak IL-6 blood concentrations were observed 1 day after the infection, with levels significantly higher in both TNF-/-LT-/- (13.5 ± 3.9 ng/ml) and TNF+/-LT+/- (22.5 ± 6.5 ng/ml), than in TNF+/+LT+/+ mice (3.8 ± 3.1 ng/ml, p < 0.05). On days 3 and 7, the circulating IL-6 concentrations had decreased considerably and did not differ between groups (data not shown). To test whether these differences in circulating cytokine concentrations were solely due to the different fungal load in the TNF-/-LT-/- and TNF+/+LT+/+ mice, or to differences in the cytokine production capacity of individual cells from the two mouse strains, resident peritoneal macrophages from TNF-/-LT-/- and TNF+/+LT+/+ mice were stimulated with 1 ng/ml LPS or 107 CFU heat-killed C. albicans in vitro for 24 h. The production of TNF by control (+/+) macrophages in response to Candida stimulation (Fig. 4GoB) was greater than that after LPS stimulation (Fig. 4GoA), whereas LPS was a stronger stimulus of the synthesis of IL-1{beta} and IL-6 (Fig. 4Go, A and B). IL-1{alpha} was induced in similar amounts by LPS (Fig. 4GoA) and C. albicans (Fig. 4GoB). Macrophages obtained from TNF-/-LT-/- mice did not produce TNF, and moreover they synthesized significantly lower amounts of IL-1{alpha}, IL-1{beta}, and IL-6 than macrophages of TNF+/+LT+/+ animals did (Fig. 4Go), in agreement with earlier observations with LPS stimulation in vitro (31). Moreover, macrophages of TNF-/-LT-/- also displayed an impaired capacity to synthesize chemokines, as their production of MIP-1{alpha} was significantly lower than that in control macrophages (204 ± 72 vs 713 ± 181 pg/ml, p < 0.05).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 4. In vitro cytokine production. Resident peritoneal macrophages from TNF+/+LT+/+ and TNF-/-LT-/- mice stimulated in vitro with either LPS (1 ng/ml) (A) or heat-killed C. albicans (107 CFU/ml) (B). TNF-/-LT-/- macrophages (filled bars) produced no TNF, and significantly less cell-associated IL-1{alpha}, and secreted less IL-1{beta} and IL-6, than TNF+/+LT+/+ macrophages (open bars). *, p < 0.05.

 
Polymorphonuclear neutrophils are the most important cell population for the defense against C. albicans, and neutropenic mice are more susceptible to disseminated candidiasis (17). To investigate the role of neutrophils in the TNF- and LT-mediated protection, groups of neutropenic TNF-/-LT-/- and normal mice were infected with 104 CFU C. albicans. As shown in Table IIGo, the outgrowth of Candida in the organs of neutropenic mice was increased compared with those of nonneutropenic mice, but the fungal load in the organs of cyclophosphamide-treated TNF-/-LT-/- or TNF+/+LT+/+ mice did not differ at days 1 and 3 of infection, suggesting that the beneficial effects of endogenous TNF and LT during systemic candidiasis are mediated through activation of neutrophils. Likewise, survival during disseminated candidiasis did not differ in neutropenic TNF-/-LT-/- or TNF+/+LT+/+ mice (50 vs 44%, p > 0.05).


View this table:
[in this window]
[in a new window]
 
Table II. The outgrowth of C. albicans in the organs of mice rendered neutropenic by cyclophosphamide after infection with 104 CFU C. albicans/mouse

 
Recruitment of PMN

To investigate the recruitment of neutrophils at the site of a C. albicans infection, groups of TNF-/-LT-/- and TNF+/+LT+/+ mice were infected i.p. with 107 CFU C. albicans, and exudate peritoneal neutrophils were harvested and counted 2 and 4 h later. As shown in Fig. 5Go, there was significantly less infiltration of neutrophils in the peritoneal cavity of TNF-/-LT-/- than in that of TNF+/+LT+/+ mice. At 24 h after infection, a similar difference between the two mouse strains was found (data not shown).



View larger version (10K):
[in this window]
[in a new window]
 
FIGURE 5. Recruitment of neutrophils. TNF+/+LT+/+ mice ({circ}) and TNF-/-LT-/- mice ({triangleup}) were injected i.p. with 107 CFU Candida per mouse. Two and four hours later, fewer neutrophils infiltrate the peritoneal cavity of TNF-/-LT-/- mice than of TNF+/+LT+/+ controls. *, p < 0.05.

 
Phagocytosis and killing of C. albicans

Phagocytosis of C. albicans by PMN of TNF-/-LT-/- mice was significantly reduced compared with that by PMN of TNF+/+LT+/+ mice (p < 0.05 by Kruskal-Wallis ANOVA) (Fig. 6GoA). Addition of exogenous murine rTNF to the neutrophils of TNF-/-LT-/- mice restored the normal phagocytic capacity (Fig. 6GoA). It has been shown that exogenous TNF is able to increase the Candida-killing capacities of neutrophils in vitro (20). Neutrophils of TNF-/-LT-/- mice tended to show a decreased killing of C. albicans after 2 or 4 h of incubation compared with neutrophils of TNF+/+LT+/+ mice (67 ± 11% vs 82 ± 11% after 4 h), although these differences were not significant (p > 0.05; Fig. 6GoB). Superoxide production by PMN of TNF-/-LT-/- mice was similar to that by PMN of TNF+/+LT+/+ control mice (0.15 ± 0.04 vs 0.17 ± 0.07 mV.s/PMN, p > 0.05).



View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 6. Phagocytosis and killing of Candida by neutrophils. A, Peritoneal neutrophils were obtained 4 h after i.p. injection of 10% proteose peptone, and C. albicans was added to the cells. Phagocytosis of C. albicans blastospores after 5 and 15 min is shown for neutrophils of TNF-/-LT-/- mice (hatched bars) and of TNF+/+LT+/+ mice (open bars). Data represent the mean ± SD for two experiments (p < 0.05, Kruskal-Wallis ANOVA). Addition of exogenous murine rTNF to the neutrophils of TNF-/-LT-/- mice restored the normal phagocytic capacity (solid bars). B, Intracellular killing of phagocytized C. albicans blastospores by neutrophils of TNF+/+LT+/+ (open bars) and TNF-/-LT-/- (hatched bars) mice, after 1, 2, and 3 h of incubation. No significant differences were found.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In the present study, it is shown that TNF-/-LT-/- mice lacking functional TNF and LT are highly susceptible to a systemic infection with C. albicans, and this is due to a 10–1000-fold increased fungal outgrowth in their organs. Experiments performed in granulocytopenic TNF+/+LT+/+ and TNF-/-LT-/- mice demonstrate that neutrophils are the main mediators of these effects. Reduced recruitment of neutrophils at the site of infection and impaired phagocytosis by PMN are responsible for the blunted immune response against Candida in the TNF-/-LT-/- mice. Although not as dramatic as in the case of homozygous TNF-/-LT-/- mice, the resistance of heterozygous TNF+/-LT+/- mice against disseminated candidiasis was also considerably impaired. This phenomenon may be explained by the absence of the positive feedback of TNF-induced TNF production that has been reported in the heterozygous TNF+/-LT+/- mice (22).

Endogenous TNF is important for a proper activation of the host defense during infections such as bacterial peritonitis (9), Mycobacterium sp. (8, 32), and Listeria monocytogenes (7) infections. Because both TNF and LT interact with the same membrane receptors and have similar effects, the absence of one of these two cytokines may be partly compensated by actions exerted by the other one. To exclude the possible redundant effects of the two cytokines, we investigated the course of disseminated candidiasis in double knockout mice, lacking both functional TNF and LT. The results of the present study demonstrate a crucial role of TNF and/or LT in the defense against C. albicans infection, and this is in line with the deleterious effects of TNF inactivation in systemic candidiasis (12, 13). A recent study has also reported an increased susceptibility of TNFRp55-/- and TNFRp75-/- mice to C. albicans (14), and it has been suggested that the most important effects of TNF during Candida infection are mediated through TNFRp55, whereas TNFRp75 would have a secondary role (14). The crucial role of the signals mediated through TNF receptors for the defense against C. albicans is not an isolated phenomenon, as the TNFRp55-/- mice are highly susceptible to L. monocytogenes (33, 34), Mycobacterium tuberculosis (32), and Toxoplasma gondii (35), and the TNF-/- mice succumb more easily to Corynebacterium parvum infection (36).

In previous studies, the mechanisms mediating the increased susceptibility of TNF-/- or TNFR-/- mice to C. albicans infection have not been elucidated. The increased fungal burden in the TNF-/-LT-/- mice as early as 1 day after the infection may suggest that an altered distribution and/or clearance of Candida in the initial stages of the infection may have influenced the invasion of the organs, leading to differences in the initial organ burden. However, the clearance from the blood and the distribution of C. albicans to the liver, spleen, kidneys, lung, heart, and brain during the first 24 h were similar in the wild-type and knockout mice. Thus, the differences in outgrowth later in the infection are expected to involve mechanisms unrelated to effects in the initial stages of infection.

TNF is able to stimulate the anticandidal properties of neutrophils (20), and this is associated with an increased production of oxygen radicals (21). These in vitro data, together with the severe course of disseminated candidiasis in neutropenic mice (17), suggest that neutrophils are the main effector cells responsible for the defense against C. albicans infection (15). Indeed, when both wild-type and TNF-/-LT-/- mice were rendered neutropenic by cyclophosphamide, the mortality was high in both groups, and no difference in the colony count of C. albicans in the organs of the two mouse strains was observed. This observation suggests that the presence of neutrophils is crucial for the protective effects of endogenous TNF against Candida. It should, however, be noted that cyclophosphamide treatment also influences, although to a much lesser extent, the lymphocyte population (25, 27), and an influence of this effect on anticandidal defense cannot be excluded.

The lack of functional TNF and LT could affect neutrophil function at several levels. The first step in the action of neutrophils during an infection is attachment to the activated endothelial cells and migration into the infected tissues. In the present study, the histology of the kidneys in the TNF-/-LT-/- mice shows a significant delay in the neutrophil infiltration at the site of infection. Consequently, the neutrophil-mediated inhibition of hyphal formation that is apparent in control mice and that is important for the defense against Candida (37) is severely impaired in the TNF-/-LT-/- mice, leading to extensive growth of C. albicans. Impaired recruitment of neutrophils in TNF-/-LT-/- mice is also present after an i.p. infection with Candida. Similar defects in recruitment of neutrophils have been observed during a Micropolyspora faeni infection in TNF-Rp55-/- mice (38).

The mechanisms responsible for the impaired recruitment of neutrophils in the TNF-/-LT-/- mice could involve defective expression of adhesion molecules on the leukocytes and endothelial cells of these mice. Attachment of neutrophils to the endothelial cells is mediated through expression of adhesion molecules such as E-selectin and ICAM-1 on the endothelium and the corresponding ligands on the neutrophils (39, 40). TNF is an important stimulus of their expression (41), and mice deficient in TNFRp55-/- fail to express normal amounts of adhesion molecules (42). As a result, homing of lymphocytes in the lymphoid organs of these mice is defective, with disturbed lymphoid organ architecture (42). In addition, reduced expression of the adhesion molecules due to the lack of TNF and LT may also impair recruitment of neutrophils and have deleterious effects during systemic candidiasis in the TNF-/-LT-/- mice. Impaired expression of adhesion molecules such as the {beta}2 integrins may have an additional effect, because it has been shown that leukocytes utilize CD11b/CD18 for recognition and binding of C. albicans (43). The importance of proper expression of these molecules for the Candida infection is underlined by a recent study showing that ICAM-1 knockout mice are more susceptible to C. albicans infection (44). In addition, TNF is an important stimulus of chemokine production (3), and macrophages from TNF-/-LT-/- mice produced significantly less MIP-1{alpha} compared with macrophages from control TNF+/+LT+/+ mice. This effect may also have contributed to the reduced and delayed PMN recruitment in TNF-/-LT-/- animals.

Another possible target for the effects of TNF on neutrophils is represented by the candidacidal mechanisms. Phagocytosis of C. albicans by PMN of TNF-/-LT-/- mice was impaired compared with phagocytosis by PMN of control animals, and the requirement of TNF for phagocytosis was confirmed by restoration of phagocytic activity of TNF-/-LT-/- neutrophils after addition of rmTNF. In addition, previous in vitro studies have also shown that TNF is able to enhance the capacity of neutrophils to kill C. albicans, and an impaired killing capacity of the neutrophils of TNF-/-LT-/- mice could have been expected. However, the neutrophils of knockout mice were as potent as their wild-type counterparts to kill Candida, and this was accompanied by a similar production of superoxide. These results are consistent with previous studies showing normal oxygen radical production by neutrophils of TNF-/- mice (36) and normal killing of Leishmania major by macrophages of TNFRp55-/- mice (45). Another possible killing mechanism influenced by TNF could have been the nitric oxide production, but previous studies have shown normal nitric oxide production by cells of TNF-/- (36), TNFRp55-/-, and TNFRp75-/- mice (35).

The data presented in this study suggest that neutrophils are the main cells mediating the beneficial effects of endogenous TNF during systemic candidiasis. However, the possible involvement of other cell types cannot be ruled out. Several studies in the literature have underlined the involvement of a Th1/Th2 imbalance in the increased susceptibility to C. albicans infection (for review, see Ref. 46). Indeed, an impaired Th1 response in TNF-/- mice has been suggested recently (47), and this may have contributed to the increased susceptibility of these mice to C. albicans infection. The protective effect of a Th1 response is, however, probably mediated through neutrophils, because IFN-{gamma} activates polymorphonuclear neutrophils for killing of Candida (20), and its beneficial effects during candidiasis are absent in neutropenic mice (18). The monocytes and macrophages are probably less involved, as murine macrophages are only able to kill C. albicans in vitro to a minor degree, and monocyte-depleted mice do not show an increased susceptibility to candidiasis (17).

In addition to TNF and LT, the production capacity of other cytokines such as IL-1{alpha}, IL-1{beta}, and IL-6 by macrophages of TNF-/-LT-/- mice was also significantly impaired compared with normal mice. This effect could be due to either a defect in the ability of TNF-/-LT-/- macrophages to produce these cytokines, or an indirect involvement of endogenous TNF or LT in the production of other cytokines. Indeed, an important proportion of the LPS-mediated synthesis of IL-1, IL-6, and MIP-1{alpha} has been shown to be mediated through intermediary production of endogenous TNF-like molecules (48, 49). The normal production of IL-1 and IL-6 by TNF-/- mice in which the gene for LT was intact (36, 50) suggests an important role of LT deficiency for the decreased production of these cytokines in the TNF-/-LT-/- mice. IL-1 and IL-6 can also contribute to the defense against C. albicans (51, 52), and the relative deficiency in the production of these cytokines could have also contributed to the increased susceptibility of TNF-/-LT-/- to systemic candidiasis. In vivo, the higher circulating concentrations of IL-6 in the TNF-/-LT-/- mice are probably due to the much higher fungal load in the deficient animals, resulting in more cellular stimulation than in the wild-type counterparts.


    Acknowledgments
 
We thank Margo van den Brink and Monique Bakker for the assistance with the animal experiments, and Ineke Verschueren for the cytokine analysis.


    Footnotes
 
1 Address correspondence and reprint requests to Dr. Bart Jan Kullberg, Department of Medicine (541), University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail address: Back

2 Abbreviations used in this paper: LT, lymphotoxin-{alpha}; MIP-1{alpha}, macrophage-inflammatory protein-1{alpha}; PMN, polymorphonuclear neutrophils. Back

Received for publication July 14, 1998. Accepted for publication May 12, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. Van der Horst, J. E. Edwards, R. G. Washburn, W. M. Scheld, A. W. Karchmer, A. P. Dine, M. J. Levenstein, C. D. Webb, 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325.[Abstract/Free Full Text]
  2. Beutler, B. E.. 1992. Tumor Necrosis Factors: The Molecules and Their Emerging Roles in Medicine Raven Press, New York.
  3. Bazzoni, F., B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717.[Free Full Text]
  4. Parillo, J. E., M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Connion, F. P. Ognobene. 1990. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227.
  5. Beutler, B., I. W. Milsark, A. C. Cerami. 1985. Passive immunization against cachexin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869.[Abstract/Free Full Text]
  6. Tracey, K. J., Y. Fong, D. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662.[Medline]
  7. Nakane, A., T. Minagawa, K. Kato. 1988. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect. Immun. 56:2563.[Abstract/Free Full Text]
  8. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, P. Vassali. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731.[Medline]
  9. Echtenacher, B., W. Falk, D. N. Mannel, P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762.[Abstract]
  10. Vecchiarelli, A., M. Puliti, A. Torosantucci, A. Cassone, F. Bistoni. 1991. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell. Immunol. 134:65.[Medline]
  11. Riipi, L., E. Carlson. 1990. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase. Infect. Immun. 58:2750.[Abstract/Free Full Text]
  12. Steinshamn, S., A. Waage. 1992. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun. 60:4003.[Abstract/Free Full Text]
  13. Netea, M. G., W. L. Blok, B. J. Kullberg, M. Bemelmans, M. T. E. Vogels, W. A. Buurman, J. W. M. Van der Meer. 1995. Pharmacological inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J. Infect. Dis. 171:393.[Medline]
  14. Steinshamn, S., M. H. A. Bemelmans, L. H. J. Van Tits, K. Bergh, W. A. Buurman, A. Waage. 1996. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J. Immunol. 157:2155.[Abstract]
  15. Kullberg, B. J.. 1997. Trends in immunotherapy of fungal infections. Eur. J. Clin. Microbiol. Infect. Dis. 16:51.[Medline]
  16. Leijh, P. C. J., M. T. Van den Barselaar, R. Van Furth. 1977. Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect. Immun. 17:313.[Abstract/Free Full Text]
  17. Van’t Wout, J. W., I. Linde, P. C. J. Leijh, R. Van Furth. 1988. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infections. Eur. J. Clin. Microbiol. Infect. Dis. 7:736.[Medline]
  18. Kullberg, B. J., J. W. Van’t Wout, C. Hoogstraten, R. Van Furth. 1993. Recombinant interferon-{gamma} enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. 168:436.[Medline]
  19. Kullberg, B. J., M. G. Netea, J. H. A. J. Curfs, M. Keuter, J. F. G. M. Meis, J. W. M. Van der Meer. 1998. Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in non-neutropenic mice. J. Infect. Dis. 177:175.[Medline]
  20. Djeu, J. Y., D. K. Blanchard, D. Halkias, H. Friedman. 1986. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-{gamma} and tumor necrosis factor. J. Immunol. 137:2980.[Abstract]
  21. Ferrante, A.. 1989. Tumor necrosis factor {alpha} potentiates neutrophil antimicrobial activity: increased fungal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun. 57:2115.[Abstract/Free Full Text]
  22. Amiot, F., O. Boussadia, S. Cases, C. Fitting, M. Lebastard, J.-M. Cavaillon, G. Millon, F. Dautry. 1997. Mice heterozygous for a deletion of the tumor necrosis factor-{alpha} and lymphotoxin-{alpha} genes: biological importance of a nonlinear response of tumor necrosis factor-{alpha} to gene dosage. Eur. J. Immunol. 27:1035.[Medline]
  23. Lehrer, R. I., M. J. Cline. 1969. Interactions of Candida albicans with human leukocytes and serum. J. Bacteriol. 98:996.[Abstract/Free Full Text]
  24. Kullberg, B. J., J. W. Van’t Wout, R. Van Furth. 1990. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. 58:3319.[Abstract/Free Full Text]
  25. Van’t Wout, J. W., I. Linde, P. C. J. Leijh, R. Van Furth. 1989. Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction. Inflammation 13:1.[Medline]
  26. Kullberg, B. J., J. W. Van’t Wout, R. Van Furth. 1991. No effect of recombinant human interleukin-1 on the numbers of peripheral blood and peritoneal leukocytes during an acute inflammation. Inflammation 15:457.[Medline]
  27. Balow, J. E.. 1975. Cyclophosphamide suppression of established cell-mediated immunity. J. Clin. Invest. 56:65.
  28. Amiot, F., Y. Bellkaid, M. Lebastard, P. Ave, F. Dautry, G. Milon. 1996. Abnormal organization of the splenic marginal zone and the correlated leukocytosis in lymphotoxin-{alpha} and tumor necrosis factor-{alpha} double deficient mice. Eur. Cytokine Netw. 7:733.[Medline]
  29. Lundqvist, H., C. Dahlgren. 1996. Isoluminol-enhanced chemluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic. Biol. Med. 20:785.[Medline]
  30. Netea, M. G., P. N. M. Demacker, B. J. Kullberg, O. C. Boerman, I. Verschueren, A. F. H. Stalenhoef, J. W. M. Van der Meer. 1996. Low-density-lipoprotein receptor deficient mice are protected against lethal endotoxinemia and severe Gram-negative infections. J. Clin. Invest. 97:1366.[Medline]
  31. Amiot, F., C. Fitting, K. J. Tracey, J. M. Cavaillon, F. Dautry. 1997. Lipopolysaccharide-induced cytokine cascade and lethality in lymphotoxin-{alpha}/tumor necrosis factor-{alpha} deficient mice. Mol. Med. 3:864.[Medline]
  32. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, B. R. Bloom. 1995. Tumor necrosis factor is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.[Medline]
  33. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.[Medline]
  34. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.[Medline]
  35. Yap, G. S., T. Scharton-Kersten, H. Charest, A. Sher. 1998. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160:1340.[Abstract/Free Full Text]
  36. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093.[Abstract/Free Full Text]
  37. Lo, H.-J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939.
  38. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.[Abstract/Free Full Text]
  39. Loftus, J. C., R. C. Liddington. 1997. New insights into integrin-ligand interaction. J. Clin. Invest. 99:2302.[Medline]
  40. Kansas, G. S.. 1996. Selectins and their ligands: current concepts and controversies. Blood 88:3259.[Free Full Text]
  41. Ward, P. A.. 1997. Recruitment of inflammatory cells into lung: roles of cytokines, adhesion molecules, and complement. J. Lab. Clin. Med. 129:400.[Medline]
  42. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. W. Mak, B. Holzmann, M. Kronke. 1996. Crucial role for 55-kilodalton receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587.[Abstract]
  43. Forsyth, C. B., H. L. Mathews. 1996. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. Cell. Immunol. 170:91.[Medline]
  44. Davis, S. L., E. P. Hawkins, E. O. Mason, C. Wayne Smith, S. L. Kaplan. 1996. Host defenses against disseminated candidiasis are impaired in intercellular adhesion molecule 1-deficient mice. J. Infect. Dis. 174:435.[Medline]
  45. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827.[Abstract]
  46. Romani, L.. 1997. The T cell response against fungal infections. Curr. Opin. Immunol. 9:484.[Medline]
  47. Mencacci, A., E. Cenci, G. Del Sero, C. Fe d’Ostiani, P. Mosci, P. Montagnoli, A. Bacci, F. Bistoni, V. F. Quesniaux, B. Ryffel, L. Romani. 1998. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-{alpha} double-deficient mice infected with Candida albicans. Int. Immunol. 10:37.[Abstract/Free Full Text]
  48. Granowitz, E. V., E. Vannier, D. D. Poutsiaka, C. A. Dinarello. 1992. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis. II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 79:2364.[Abstract/Free Full Text]
  49. Muhl, H., C. A. Dinarello. 1997. Macrophage inflammatory protein-1{alpha} production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. J. Immunol. 159:5063.[Abstract]
  50. Pasparakis, M., L. Alexopoulou, V. Episcopou, G. Kollias. 1996. Immune and inflammatory responses in TNF{alpha}-deficient mice: a critical requirement for TNF{alpha} in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397.[Abstract/Free Full Text]
  51. Van der Meer, J. W. M.. 1989. Options for the treatment of serious infections with interleukin-1. Biotherapy 1:313.[Medline]
  52. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, C. Toniatti, P. Puccetti, F. Bistoni, and V. Poli. 1996. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345.



This article has been cited by other articles:


Home page
J. Immunol.Home page
B. Balestrieri, A. Maekawa, W. Xing, M. H. Gelb, H. R. Katz, and J. P. Arm
Group V Secretory Phospholipase A2 Modulates Phagosome Maturation and Regulates the Innate Immune Response against Candida albicans
J. Immunol., April 15, 2009; 182(8): 4891 - 4898.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, and J. W. M. van der Meer
Continuous administration of PBP-2- and PBP-3-specific {beta}-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis
J. Antimicrob. Chemother., March 29, 2007; (2007) dkm073v1.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. J. Spellberg, M. Collins, V. Avanesian, M. Gomez, J. E. Edwards Jr., C. Cogle, D. Applebaum, Y. Fu, and A. S. Ibrahim
Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts
J. Leukoc. Biol., March 1, 2007; 81(3): 632 - 641.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
C. Murciano, E. Villamon, A. Yanez, J.-E. O'Connor, D. Gozalbo, and M. L. Gil
Impaired immune response to Candida albicans in aged mice.
J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1649 - 1656.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. De Bernardis, R. Lucciarini, M. Boccanera, C. Amantini, S. Arancia, S. Morrone, M. Mosca, A. Cassone, and G. Santoni
Phenotypic and Functional Characterization of Vaginal Dendritic Cells in a Rat Model of Candida albicans Vaginitis
Infect. Immun., July 1, 2006; 74(7): 4282 - 4294.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Moller-Kristensen, W. K. E. Ip, L. Shi, L. D. Gowda, M. R. Hamblin, S. Thiel, J. Chr. Jensenius, R. A. B. Ezekowitz, and K. Takahashi
Deficiency of Mannose-Binding Lectin Greatly Increases Susceptibility to Postburn Infection with Pseudomonas aeruginosa
J. Immunol., February 1, 2006; 176(3): 1769 - 1775.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. W. Spahn, H.-P. Eugster, A. Fontana, W. Domschke, and T. Kucharzik
Role of Lymphotoxin in Experimental Models of Infectious Diseases: Potential Benefits and Risks of a Therapeutic Inhibition of the Lymphotoxin-{beta} Receptor Pathway
Infect. Immun., November 1, 2005; 73(11): 7077 - 7088.
[Full Text] [PDF]


Home page
JDRHome page
A. Dongari-Bagtzoglou and P.L. Fidel Jr.
The Host Cytokine Responses and Protective Immunity in Oropharyngeal Candidiasis
Journal of Dental Research, November 1, 2005; 84(11): 966 - 977.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. S. Kim, E. H. Choi, J. Khan, E. Roilides, A. Francesconi, M. Kasai, T. Sein, R. L. Schaufele, K. Sakurai, C. G. Son, et al.
Expression of Genes Encoding Innate Host Defense Molecules in Normal Human Monocytes in Response to Candida albicans
Infect. Immun., June 1, 2005; 73(6): 3714 - 3724.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. C. Herring, N. R. Falkowski, G.-H. Chen, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Transient Neutralization of Tumor Necrosis Factor Alpha Can Produce a Chronic Fungal Infection in an Immunocompetent Host: Potential Role of Immature Dendritic Cells
Infect. Immun., January 1, 2005; 73(1): 39 - 49.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. G. Correa, M. C. Rodriguez-Galan, B. Salido-Renteria, R. Cano, H. Cejas, and C. E. Sotomayor
High dissemination and hepatotoxicity in rats infected with Candida albicans after stress exposure: potential sensitization to liver damage
Int. Immunol., December 1, 2004; 16(12): 1761 - 1768.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. B. Mann, K. D. Elder, M. J. Kennett, and E. T. Harvill
Toll-Like Receptor 4-Dependent Early Elicited Tumor Necrosis Factor Alpha Expression Is Critical for Innate Host Defense against Bordetella bronchiseptica
Infect. Immun., November 1, 2004; 72(11): 6650 - 6658.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Netea, R. Sutmuller, C. Hermann, C. A. A. Van der Graaf, J. W. M. Van der Meer, J. H. van Krieken, T. Hartung, G. Adema, and B. J. Kullberg
Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells
J. Immunol., March 15, 2004; 172(6): 3712 - 3718.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-H. Lee, L. Del Sorbo, A. A. Khine, J. de Azavedo, D. E. Low, D. Bell, S. Uhlig, A. S. Slutsky, and H. Zhang
Modulation of Bacterial Growth by Tumor Necrosis Factor-{alpha} In Vitro and In Vivo
Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. D. Brown, J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon
Dectin-1 Mediates the Biological Effects of {beta}-Glucans
J. Exp. Med., May 5, 2003; 197(9): 1119 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. C. Rodriguez-Galan, C. Sotomayor, M. E. Costamagna, A. M. Cabanillas, B. S. Renteria, A. M. Masini-Repiso, and S. Correa
Immunocompetence of macrophages in rats exposed to Candida albicans infection and stress
Am J Physiol Cell Physiol, January 1, 2003; 284(1): C111 - C118.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Wang, H. Das, A. Kamath, L. Li, and J. F. Bukowski
Human V{gamma}2V{delta}2 T Cells Augment Migration-Inhibitory Factor Secretion and Counteract the Inhibitory Effect of Glucocorticoids on IL-1{beta} and TNF-{alpha} Production
J. Immunol., May 15, 2002; 168(10): 4889 - 4896.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Magez, B. Stijlemans, G. Caljon, H.-P. Eugster, and P. De Baetselier
Control of Experimental Trypanosoma brucei Infections Occurs Independently of Lymphotoxin-{alpha} Induction
Infect. Immun., March 1, 2002; 70(3): 1342 - 1351.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Steele and P. L. Fidel Jr.
Cytokine and Chemokine Production by Human Oral and Vaginal Epithelial Cells in Response to Candida albicans
Infect. Immun., February 1, 2002; 70(2): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Choi, H. M. Ko, J.-W. Kim, H.-K. Lee, S. S. Han, S.-B. Chun, and S. Y. Im
Platelet-Activating Factor-Induced Early Activation of NF-{{kappa}}B Plays a Crucial Role for Organ Clearance of Candida albicans
J. Immunol., April 15, 2001; 166(8): 5139 - 5144.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. N. Shakhov, I. G. Lyakhov, A. V. Tumanov, A. V. Rubtsov, L. N. Drutskaya, M. W. Marino, and S. A. Nedospasov
Gene profiling approach in the analysis of lymphotoxin and TNF deficiencies
J. Leukoc. Biol., July 1, 2000; 68(1): 151 - 157.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Vazquez-Torres, G. Fantuzzi, C. K. Edwards III, C. A. Dinarello, and F. C. Fang
Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages
PNAS, February 27, 2001; 98(5): 2561 - 2565.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Netea, M. G.
Right arrow Articles by Kullberg, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Netea, M. G.
Right arrow Articles by Kullberg, B. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS